Status:

COMPLETED

Acupressure for Children in Treatment for a Childhood Cancer

Lead Sponsor:

University of California, San Francisco

Collaborating Sponsors:

Patient-Centered Outcomes Research Institute

Pierre's Birthday Fund

Conditions:

Treatment-Related Cancer

Eligibility:

All Genders

5-24 years

Phase:

NA

Brief Summary

Background: Despite advances in symptom management, children undergoing cancer treatment or receiving a chemotherapy-based Hematopoietic Stem Cell Transplant (HSCT) often suffer from moderate to sever...

Detailed Description

AIMS Aim 1: To assess the feasibility of an acupressure intervention plus usual care and to assess the benefits and risks compared to usual care alone for children receiving hospital-based treatment ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Children who are either receiving treatment for diagnosis of a childhood cancer (curative or supportive care) or are receiving a chemotherapy-based HSCT. Non-malignant brain central nervous system tumors are considered as a childhood cancer.
  • Ages 5- 24 years old.
  • Be receiving hospital-based treatment (inpatient or outpatient) so that acupressure treatments can be delivered and parents can be trained and monitored.
  • Availability and willingness of a parent or caregiver to deliver acupressure for ages 5-17. For young adults ages 18-24 participation of a parent, close friend or family member/caregiver is preferred but not required.
  • English or Spanish speaking.
  • Receiving treatment at UCSF Benioff Children's Hospital.
  • Exclusion Criteria
  • 1\) Children/young adults who meet the above criteria, but whose treating oncologist, health care provider, or a study investigator advises against study participation for physical health, mental health (parent or child) or logistical reasons.

Exclusion

    Key Trial Info

    Start Date :

    September 26 2017

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    October 1 2019

    Estimated Enrollment :

    95 Patients enrolled

    Trial Details

    Trial ID

    NCT03313193

    Start Date

    September 26 2017

    End Date

    October 1 2019

    Last Update

    October 11 2019

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    UCSF Helen Diller Family Comprehensive Cancer Center

    San Francisco, California, United States, 94115